<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>113(10)</volume><submitter>Miyamae M</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>This study aims to explore novel microRNAs in plasma for screening cancer and predicting clinical outcomes in pancreatic cancer (PCa) patients using a microRNA array-based approach.&lt;h4>Methods&lt;/h4>We used the Toray 3D-Gene microRNA array-based approach to compare plasma levels between PCa patients and healthy volunteers.&lt;h4>Results&lt;/h4>(1) Six oncogenic microRNAs (miR-615-5p, -744, -575, -557, -675, and -550a) with high expression in plasma were selected. (2) By quantitative RT-PCR using plasma samples from 94 PCa patients and 68 healthy volunteers, a significantly higher level of plasma miR-744 in PCa patients than in healthy volunteers was validated in small-scale analysis (P=0.0038), two independent cohort analyses, and large-scale analysis (P&lt;0.0001, AUC 0.8307). (3)</pubmed_abstract><journal>British journal of cancer</journal><pagination>1467-76</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4815891</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Plasma microRNA profiles: identification of miR-744 as a novel diagnostic and prognostic biomarker in pancreatic cancer.</pubmed_title><pmcid>PMC4815891</pmcid><pubmed_authors>Ochiai T</pubmed_authors><pubmed_authors>Otsuji E</pubmed_authors><pubmed_authors>Komatsu S</pubmed_authors><pubmed_authors>Shiozaki A</pubmed_authors><pubmed_authors>Ikoma H</pubmed_authors><pubmed_authors>Okamoto K</pubmed_authors><pubmed_authors>Kawaguchi T</pubmed_authors><pubmed_authors>Ichikawa D</pubmed_authors><pubmed_authors>Miyamae M</pubmed_authors><pubmed_authors>Hirajima S</pubmed_authors><pubmed_authors>Imamura T</pubmed_authors><pubmed_authors>Ohashi T</pubmed_authors><pubmed_authors>Konishi H</pubmed_authors><pubmed_authors>Taniguchi H</pubmed_authors><pubmed_authors>Okajima W</pubmed_authors><pubmed_authors>Morimura R</pubmed_authors></additional><is_claimable>false</is_claimable><name>Plasma microRNA profiles: identification of miR-744 as a novel diagnostic and prognostic biomarker in pancreatic cancer.</name><description>&lt;h4>Background&lt;/h4>This study aims to explore novel microRNAs in plasma for screening cancer and predicting clinical outcomes in pancreatic cancer (PCa) patients using a microRNA array-based approach.&lt;h4>Methods&lt;/h4>We used the Toray 3D-Gene microRNA array-based approach to compare plasma levels between PCa patients and healthy volunteers.&lt;h4>Results&lt;/h4>(1) Six oncogenic microRNAs (miR-615-5p, -744, -575, -557, -675, and -550a) with high expression in plasma were selected. (2) By quantitative RT-PCR using plasma samples from 94 PCa patients and 68 healthy volunteers, a significantly higher level of plasma miR-744 in PCa patients than in healthy volunteers was validated in small-scale analysis (P=0.0038), two independent cohort analyses, and large-scale analysis (P&lt;0.0001, AUC 0.8307). (3)</description><dates><release>2015-01-01T00:00:00Z</release><publication>2015 Nov</publication><modification>2025-04-04T20:13:20.472Z</modification><creation>2019-03-27T03:10:49Z</creation></dates><accession>S-EPMC4815891</accession><cross_references><pubmed>26505678</pubmed><doi>10.1038/bjc.2015.366</doi></cross_references></HashMap>